Development of Horse-Riding Program Model for Children With Cerebral Palsy

May 16, 2018 updated by: Bo Young Hong, The Catholic University of Korea
The purpose of this study is to develop healing riding algorithm applicable in rural riding centers and to apply this to children with cerebral palsy.

Study Overview

Status

Completed

Detailed Description

Horseback riding activities in Korea's riding centers have mostly centered on physical rehabilitation for children with special needs, including those with cerebral palsy, mental disabilities, and autism, with the program conducted by certified equine-assisted therapy instructors. However, there is no definite way to assess the ability of children for horseback riding and no standard riding program. Therefore, developing a assessment and program algorithm for healing horseback riding is expected to contribute to providing more activities for children with special needs and also for general people.

Children older than 4 years old or adolescent with cerebral palsy who voluntarily want to enroll this study would be enrolled.

Participants have 2 times of 30-minute horse riding program for 8 weeks, total 16 times of riding program in a local horse riding center.

Sample size assessment: Calculating for 20% of drop out, 16 patients were calculated to apply the assessment and applicable program.

Drop out: missing more than 2 lessons of horse-riding

Plan for missing data: not included

Statistical analysis plan: paired t-test for the outcome measures

Study Type

Interventional

Enrollment (Actual)

12

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

5 years to 18 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Children or adolescent with cerebral palsy
  • GMFCS level I, II, III
  • Body weight less than 80 kg

Exclusion Criteria:

  • Medical condition who are not suitable for hippotherapy: severe osteoporosis, mental illness, not controlled seizure disorder etc.
  • Social condition who are not suitable for hippotherapy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: hippotherapy
16 sessions of horseback riding therapy
Apply 30 minutes/session, twice a week for 8 weeks of horseback riding therapy (provided with 1 horse rider, 2 side walkers)
Other Names:
  • hippotherapy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change of gross motor function (assessment of GMFM-88)
Time Frame: Before the program starts (up to 2 weeks), After the program ends (up to 2 weeks)
Assessment of GMFM-88 before and after the 16 sessions of horse riding program
Before the program starts (up to 2 weeks), After the program ends (up to 2 weeks)
Change of Berg balance (assessment of pediatric berg balance scale)
Time Frame: Before the program starts (up to 2 weeks), After the program ends (up to 2 weeks)
Assessment of pediatric berg balance scale before and after the 16 sessions of horse riding
Before the program starts (up to 2 weeks), After the program ends (up to 2 weeks)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Actigraph (to monitor activity)
Time Frame: During the horse riding therapy/
wear an Actigraph to monitor activity of children
During the horse riding therapy/
Child Health Questionnaire (CHQ)
Time Frame: Before the program starts (up to 2 weeks), After the program ends (up to 2 weeks)
Caregivers answer the sheets
Before the program starts (up to 2 weeks), After the program ends (up to 2 weeks)
Postural Assessment Scale for Hippotherapy (PASH)
Time Frame: From starting the therapy, every 2 weeks re-evaluated through study completion, in total 4 times
Developed tool for assessment of ability for hippotherapy
From starting the therapy, every 2 weeks re-evaluated through study completion, in total 4 times

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Bo Young Hong, MD, St.Vincent's Hospital, the Catholic University of Korea

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 14, 2017

Primary Completion (Actual)

October 31, 2017

Study Completion (Actual)

October 31, 2017

Study Registration Dates

First Submitted

January 31, 2017

First Submitted That Met QC Criteria

February 2, 2017

First Posted (Estimate)

February 3, 2017

Study Record Updates

Last Update Posted (Actual)

May 18, 2018

Last Update Submitted That Met QC Criteria

May 16, 2018

Last Verified

May 1, 2018

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

1 professor in Samsung Medical Center

IPD Sharing Time Frame

When analysis is done after completion of the study

IPD Sharing Access Criteria

Primary investigator of the study

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ANALYTIC_CODE
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cerebral Palsy

Clinical Trials on Horseback riding therapy

3
Subscribe